Kandera Reinhard 4
4 · HOOKIPA Pharma Inc. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Kandera Reinhard
DirectorChief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+69,300→ 69,300 totalExercise: $12.00Exp: 2031-04-19→ Common Stock (69,300 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on April 19, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.